Alpha Cognition Inc. Increase (Decrease) in Accounts Receivable
Alpha Cognition Inc. (ACOG) reported Increase (Decrease) in Accounts Receivable of $1.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Alpha Cognition Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $1.90M, a 36.37% increase year-over-year.
- Alpha Cognition Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$657.96K, a 255.62% decline year-over-year.
- Alpha Cognition Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.39M.
- Alpha Cognition Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $1.03M.
- Alpha Cognition Inc. increase (decrease) in accounts receivable for fiscal 2025 was $4.24M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.24M 10-Q · filed 2026-08-13 | $2.63M derived: sum of 3 quarters · filed 2026-08-13 | $3.66M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$657.96K 10-Q · filed 2026-05-14 | $732.47K derived: sum of 2 quarters · filed 2026-05-14 | $1.76M derived: sum of 3 quarters · filed 2026-05-14 | $3.16M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.42M derived: sum of 2 quarters · filed 2026-03-31 | $3.81M derived: sum of 3 quarters · filed 2026-08-13 | $4.24M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.42M derived: sum of 2 quarters · filed 2026-08-13 | $2.85M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.81M 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $422.80K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |